LAVAL, QC, Oct. 4 /CNW Telbec/ - Sanofi-aventis Canada Inc., in
consultation with Health Canada, has provided new safety information regarding
the antibiotic, KETEK (telithromycin) tablets to healthcare professionals
through a Dear Doctor letter and to Canadian consumers via a public
information notice (available on the Health Canada website:
http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/index_e.html).
